Australian Doctor newspaper has reported today that routine hepatitis C and HbA1c tests, and non-invasive testing for chromosomal abnormalities have been included in new draft NHMRC guidelines on antenatal care. An article by Michael Woodhead referring to the consultation process notes:
An update to the Australian Clinical Practice Guidelines for Antenatal Care overturns previous advice against routine testing for hepatitis C, saying it is now supported because of the availability of direct-acting antivirals that can offer a rapid post-partum cure.
And when testing women at risk of diabetes, GPs providing shared antenatal care are advised that HbA1c tests may be suitable in the first trimester as an alternative to fasting plasma glucose tests.
Updated and expanded advice is provided on cell-free DNA testing for fetal chromosomal abnormalities, given that the tests are now widely available and used by many women in the first trimester.